Anxiety Disorders Completed Phase 2 Trials for Neuropeptide Y (DB11788)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00748956Intranasal Administration of Neuropeptide Y in Healthy Male VolunteersBasic Science